Onyx Pharmaceuticals to Present at JPMorgan Healthcare Conference
03 January 2007 - 8:00AM
PR Newswire (US)
EMERYVILLE, Calif., Jan. 2 /PRNewswire-FirstCall/ -- Onyx
Pharmaceuticals, Inc. (NASDAQ:ONXX) today announced that it will
present at the JPMorgan Healthcare conference on Monday, January 8,
at 8:00 a.m. Pacific Time. Interested parties may access a live
webcast of the presentation at: https://events.jpmorgan.com/ It is
recommended that listeners log on 15 minutes early in order to
register and download any necessary software. For those unable to
participate during the live webcast, a recorded replay of the
presentation will be available within 24 hours of the completion of
the presentation through February 8, 2007. Onyx Pharmaceuticals,
Inc. is a biopharmaceutical company developing innovative therapies
that target the molecular mechanisms that cause cancer. The company
is developing Nexavar(R), a small molecule drug, with Bayer
Pharmaceuticals Corporation. Nexavar has been approved for the
treatment of advanced kidney cancer. For more information about
Onyx's pipeline and activities, visit the company's web site at:
http://www.onyx-pharm.com/. NOTE: Nexavar(R) (sorafenib) tablets is
a registered trademark of Bayer Pharmaceuticals Corporation.
DATASOURCE: Onyx Pharmaceuticals, Inc. CONTACT: Alexandra Santos of
Onyx Pharmaceuticals, Inc., +1-510-597-6504 Web site:
http://www.onyx-pharm.com/
Copyright
Onyx Pharmaceuticals, Inc. (MM) (NASDAQ:ONXX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Onyx Pharmaceuticals, Inc. (MM) (NASDAQ:ONXX)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Onyx Pharmaceuticals, Inc. (MM) (NASDAQ): 0 recent articles
More Onyx Pharmaceuticals (MM) News Articles